US Stock MarketDetailed Quotes

PRME Prime Medicine

Watchlist

5.435
-0.155-2.77%

Trading May 6 09:54 ET

652.36MMarket Cap-2493P/E (TTM)

Prime Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-25.48%-165.41M

-42.82%-43.86M

-30.13%-39.17M

-101.85%-40.82M

18.18%-41.56M

-286.79%-131.83M

-132.90%-30.71M

-213.33%-30.1M

-20.22M

-50.79M

Net income from continuing operations

-62.64%-198.13M

-67.10%-65.64M

-72.77%-50.71M

-44.42%-42.39M

-65.26%-39.4M

26.33%-121.82M

37.56%-39.28M

-78.83%-29.35M

---29.35M

---23.84M

Operating gains losses

250.00%28K

----

--8K

--0

----

Depreciation and amortization

109.22%4.65M

43.33%1.25M

95.88%1.24M

160.00%1.12M

259.04%1.05M

291.55%2.22M

279.91%870K

277.84%631K

--430K

--293K

Deferred tax

71.06%-279K

--0

-150.94%-108K

107.01%31K

62.03%-202K

-54.49%-964K

-116.25%-202K

108.95%212K

---442K

---532K

Other non cash items

30.62%12.79M

19.66%3.35M

13.21%3.14M

41.93%3.47M

59.49%2.83M

-89.94%9.79M

-96.81%2.8M

103.79%2.77M

--2.45M

--1.78M

Change In working capital

107.48%2.65M

1,133.99%14.45M

162.34%2.4M

-456.70%-5.59M

74.87%-8.62M

-213.55%-35.4M

-96.29%1.17M

-393.33%-3.85M

--1.57M

---34.29M

-Change in prepaid assets

-444.02%-9.46M

36.93%-415K

-260.75%-3.74M

-1,098.21%-4.01M

-540.07%-1.29M

-96.38%-1.74M

-170.78%-658K

-171.47%-1.04M

---335K

--292K

-Change in payables and accrued expense

204.20%24.4M

304.78%18.29M

1,625.97%8.44M

-42.46%2.22M

85.90%-4.55M

-164.34%-23.42M

-86.47%4.52M

-25.46%489K

--3.85M

---32.27M

-Change in other current liabilities

-19.98%-12.3M

-27.40%-3.43M

30.30%-2.3M

-94.26%-3.79M

-20.49%-2.78M

-136.67%-10.25M

-69.61%-2.69M

-213.09%-3.3M

---1.95M

---2.31M

Cash from discontinued investing activities

Operating cash flow

-25.48%-165.41M

-42.82%-43.86M

-30.13%-39.17M

-101.85%-40.82M

18.18%-41.56M

-286.79%-131.83M

-132.90%-30.71M

-213.33%-30.1M

---20.22M

---50.79M

Investing cash flow

Cash flow from continuing investing activities

139.73%18.71M

401.64%41.29M

-179.55%-37.77M

154.85%27.86M

-141.00%-12.67M

36.03%-47.1M

-212.61%-13.69M

-76.94%-13.51M

-50.79M

30.89M

Net PPE purchase and sale

45.80%-8.72M

61.78%-1.84M

39.28%-2.91M

58.85%-1.98M

-18.42%-2M

-287.83%-16.1M

-1,160.21%-4.81M

-162.66%-4.79M

---4.8M

---1.69M

Net investment purchase and sale

191.00%27.61M

586.08%43.13M

-299.78%-34.86M

166.32%30.01M

-132.82%-10.67M

56.02%-30.34M

-168.98%-8.87M

-47.30%-8.72M

---45.24M

--32.5M

Net other investing changes

74.44%-170K

--0

----

-34.07%-665K

99.69%-1K

--0

---745K

--81K

Cash from discontinued investing activities

Investing cash flow

139.73%18.71M

401.64%41.29M

-179.55%-37.77M

154.85%27.86M

-141.00%-12.67M

36.03%-47.1M

-212.61%-13.69M

-76.94%-13.51M

---50.79M

--30.89M

Financing cash flow

Cash flow from continuing financing activities

-99.64%655K

-99.89%194K

146.56%318K

112.02%75K

105.35%68K

-32.60%181.49M

17,049.63%184.07M

-68,200.00%-683K

-624K

-1.27M

Net common stock issuance

--0

----

--185.32M

----

Proceeds from stock option exercised by employees

199.09%655K

24.36%194K

404.76%318K

--75K

--68K

--219K

--156K

--63K

--0

Net other financing activities

----

-272.19%-4.04M

---1.4M

---746K

---624K

---1.27M

Cash from discontinued financing activities

Financing cash flow

-99.64%655K

-99.89%194K

146.56%318K

112.02%75K

105.35%68K

-32.60%181.49M

17,049.63%184.07M

-68,200.00%-683K

---624K

---1.27M

Net cash flow

Beginning cash position

1.29%201.12M

-6.49%57.46M

26.80%134.07M

-17.15%146.96M

1.29%201.12M

436.97%198.55M

-69.38%61.44M

-51.48%105.74M

--177.37M

--198.55M

Current changes in cash

-5,780.51%-146.05M

-101.71%-2.39M

-72.98%-76.62M

82.01%-12.89M

-155.80%-54.16M

-98.41%2.57M

6,691.46%139.67M

-156.87%-44.29M

---71.64M

---21.17M

End cash Position

-72.62%55.07M

-6.49%57.46M

26.80%134.07M

-17.15%146.96M

1.29%201.12M

-69.38%61.44M

--105.74M

--177.37M

Free cash flow

-17.72%-174.14M

-28.65%-45.7M

-20.60%-42.08M

-71.02%-42.8M

17.00%-43.56M

-286.91%-147.92M

-161.82%-35.53M

-205.24%-34.89M

---25.03M

---52.48M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-25.48%-165.41M	-42.82%-43.86M	-30.13%-39.17M	-101.85%-40.82M	18.18%-41.56M	-286.79%-131.83M	-132.90%-30.71M	-213.33%-30.1M	-20.22M	-50.79M
Net income from continuing operations	-62.64%-198.13M	-67.10%-65.64M	-72.77%-50.71M	-44.42%-42.39M	-65.26%-39.4M	26.33%-121.82M	37.56%-39.28M	-78.83%-29.35M	---29.35M	---23.84M
Operating gains losses	250.00%28K	----	----	----	----	--8K	--0	----	----	----
Depreciation and amortization	109.22%4.65M	43.33%1.25M	95.88%1.24M	160.00%1.12M	259.04%1.05M	291.55%2.22M	279.91%870K	277.84%631K	--430K	--293K
Deferred tax	71.06%-279K	--0	-150.94%-108K	107.01%31K	62.03%-202K	-54.49%-964K	-116.25%-202K	108.95%212K	---442K	---532K
Other non cash items	30.62%12.79M	19.66%3.35M	13.21%3.14M	41.93%3.47M	59.49%2.83M	-89.94%9.79M	-96.81%2.8M	103.79%2.77M	--2.45M	--1.78M
Change In working capital	107.48%2.65M	1,133.99%14.45M	162.34%2.4M	-456.70%-5.59M	74.87%-8.62M	-213.55%-35.4M	-96.29%1.17M	-393.33%-3.85M	--1.57M	---34.29M
-Change in prepaid assets	-444.02%-9.46M	36.93%-415K	-260.75%-3.74M	-1,098.21%-4.01M	-540.07%-1.29M	-96.38%-1.74M	-170.78%-658K	-171.47%-1.04M	---335K	--292K
-Change in payables and accrued expense	204.20%24.4M	304.78%18.29M	1,625.97%8.44M	-42.46%2.22M	85.90%-4.55M	-164.34%-23.42M	-86.47%4.52M	-25.46%489K	--3.85M	---32.27M
-Change in other current liabilities	-19.98%-12.3M	-27.40%-3.43M	30.30%-2.3M	-94.26%-3.79M	-20.49%-2.78M	-136.67%-10.25M	-69.61%-2.69M	-213.09%-3.3M	---1.95M	---2.31M
Cash from discontinued investing activities
Operating cash flow	-25.48%-165.41M	-42.82%-43.86M	-30.13%-39.17M	-101.85%-40.82M	18.18%-41.56M	-286.79%-131.83M	-132.90%-30.71M	-213.33%-30.1M	---20.22M	---50.79M
Investing cash flow
Cash flow from continuing investing activities	139.73%18.71M	401.64%41.29M	-179.55%-37.77M	154.85%27.86M	-141.00%-12.67M	36.03%-47.1M	-212.61%-13.69M	-76.94%-13.51M	-50.79M	30.89M
Net PPE purchase and sale	45.80%-8.72M	61.78%-1.84M	39.28%-2.91M	58.85%-1.98M	-18.42%-2M	-287.83%-16.1M	-1,160.21%-4.81M	-162.66%-4.79M	---4.8M	---1.69M
Net investment purchase and sale	191.00%27.61M	586.08%43.13M	-299.78%-34.86M	166.32%30.01M	-132.82%-10.67M	56.02%-30.34M	-168.98%-8.87M	-47.30%-8.72M	---45.24M	--32.5M
Net other investing changes	74.44%-170K	--0	--0	----	----	-34.07%-665K	99.69%-1K	--0	---745K	--81K
Cash from discontinued investing activities
Investing cash flow	139.73%18.71M	401.64%41.29M	-179.55%-37.77M	154.85%27.86M	-141.00%-12.67M	36.03%-47.1M	-212.61%-13.69M	-76.94%-13.51M	---50.79M	--30.89M
Financing cash flow
Cash flow from continuing financing activities	-99.64%655K	-99.89%194K	146.56%318K	112.02%75K	105.35%68K	-32.60%181.49M	17,049.63%184.07M	-68,200.00%-683K	-624K	-1.27M
Net common stock issuance	--0	----	----	----	----	--185.32M	----	----	----	----
Proceeds from stock option exercised by employees	199.09%655K	24.36%194K	404.76%318K	--75K	--68K	--219K	--156K	--63K	--0	--0
Net other financing activities	----	----	----	----	----	-272.19%-4.04M	---1.4M	---746K	---624K	---1.27M
Cash from discontinued financing activities
Financing cash flow	-99.64%655K	-99.89%194K	146.56%318K	112.02%75K	105.35%68K	-32.60%181.49M	17,049.63%184.07M	-68,200.00%-683K	---624K	---1.27M
Net cash flow
Beginning cash position	1.29%201.12M	-6.49%57.46M	26.80%134.07M	-17.15%146.96M	1.29%201.12M	436.97%198.55M	-69.38%61.44M	-51.48%105.74M	--177.37M	--198.55M
Current changes in cash	-5,780.51%-146.05M	-101.71%-2.39M	-72.98%-76.62M	82.01%-12.89M	-155.80%-54.16M	-98.41%2.57M	6,691.46%139.67M	-156.87%-44.29M	---71.64M	---21.17M
End cash Position	-72.62%55.07M	-72.62%55.07M	-6.49%57.46M	26.80%134.07M	-17.15%146.96M	1.29%201.12M	1.29%201.12M	-69.38%61.44M	--105.74M	--177.37M
Free cash flow	-17.72%-174.14M	-28.65%-45.7M	-20.60%-42.08M	-71.02%-42.8M	17.00%-43.56M	-286.91%-147.92M	-161.82%-35.53M	-205.24%-34.89M	---25.03M	---52.48M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall